Through its Orange Digital Investment holding, the Orange Group has decided to invest in the Digital Health 2 (DH2) fund of LBO France — a major player in the private equity sector in France.
The DH2 fund plans to invest €200 million in e-health SMEs, such as QuantifiCare, Tribvn Healthcare, FeetMe and Meditect, dedicated to B2B in the growth phase in France and Western Europe. Convinced of the potential of the e-health market, undergoing transformation thanks to the benefits of digital technology, Orange is providing additional resources to DH2 with a view to develop innovative e-health companies in France and Europe.
According to Orange, this initiative will have a positive impact both for the companies selected by the DH2 fund management team and for the entire e-health ecosystem. This will enable for both holding companies and investors alike: - the development of more operational synergies in pursuit of innovation, - an active contribution to the development of an area of excellence in the e-health field and the strengthening of Orange’s strategic positioning in this regard. By investing in a dynamic fund, managed by a recognized management team that is open to cooperation with the Orange Group, Enovacom sees an opportunity to consolidate its privileged access to the innovative e-health ecosystem.
Valéry Huot Partner, Head of Venture at LBO France
The presence of a global operator, integrator of digital services, and a pioneer in e-health within the DH2 fund, is a definite advantage for the portfolio companies.
Laurent Frigara, Deputy CEO of Enovacom (Orange Business Services)
We are convinced that DH2’s management team will be able to identify and support the hidden gems of the e-health industry to make companies both currently in the portfolio and those of tomorrow major players in e-health.
